<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang L</submitter><funding>National Natural Science Foundation of China for Young Scientists</funding><funding>Special Fund of Guangxi University of Chinese Medicine</funding><funding>Innovation Project of Guangxi Graduate Education of GXUCM</funding><pagination>824</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12196505</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(6)</volume><pubmed_abstract>&lt;b>Background/Objectives:&lt;/b>&lt;i>Camellia nitidissima&lt;/i> Chi (&lt;i>C. nitidissima&lt;/i>), a traditional Chinese "food and medicine homology" plant, has demonstrated potential anti-tumor properties. However, its mechanisms of anti-lung cancer activity via ferroptosis remain unclear. This study aimed to construct an integrated research system of "natural product extraction-purification, bioactivity evaluation, and computational drug screening" to explore the bioactive compounds in &lt;i>C. nitidissima&lt;/i> leaves targeting HMOX-1-mediated ferroptosis and their anti-lung cancer mechanisms. &lt;b>Methods:&lt;/b> Active fractions were prepared using ethanol extraction combined with polyamide column chromatography. The anti-lung cancer activity was evaluated using the NCI-H1975 cell model. Ferroptosis was ver</pubmed_abstract><journal>Pharmaceuticals (Basel, Switzerland)</journal><pubmed_title>Identification of HMOX-1-Targeting Natural Compounds in &amp;lt;i&amp;gt;Camellia nitidissima&amp;lt;/i&amp;gt; Chi for NSCLC Therapy: Integrating Bioassay and In Silico Screening Approaches.</pubmed_title><pmcid>PMC12196505</pmcid><funding_grant_id>82204756</funding_grant_id><funding_grant_id>YCSY2023056</funding_grant_id><funding_grant_id>2025GXNSFAA069904</funding_grant_id><pubmed_authors>Liang C</pubmed_authors><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Xie J</pubmed_authors><pubmed_authors>Qin X</pubmed_authors><pubmed_authors>Deng J</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Du Z</pubmed_authors><pubmed_authors>Hou X</pubmed_authors><pubmed_authors>Zhong M</pubmed_authors><pubmed_authors>Mo Y</pubmed_authors><pubmed_authors>Hao E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of HMOX-1-Targeting Natural Compounds in &amp;lt;i&amp;gt;Camellia nitidissima&amp;lt;/i&amp;gt; Chi for NSCLC Therapy: Integrating Bioassay and In Silico Screening Approaches.</name><description>&lt;b>Background/Objectives:&lt;/b>&lt;i>Camellia nitidissima&lt;/i> Chi (&lt;i>C. nitidissima&lt;/i>), a traditional Chinese "food and medicine homology" plant, has demonstrated potential anti-tumor properties. However, its mechanisms of anti-lung cancer activity via ferroptosis remain unclear. This study aimed to construct an integrated research system of "natural product extraction-purification, bioactivity evaluation, and computational drug screening" to explore the bioactive compounds in &lt;i>C. nitidissima&lt;/i> leaves targeting HMOX-1-mediated ferroptosis and their anti-lung cancer mechanisms. &lt;b>Methods:&lt;/b> Active fractions were prepared using ethanol extraction combined with polyamide column chromatography. The anti-lung cancer activity was evaluated using the NCI-H1975 cell model. Ferroptosis was ver</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-04-15T03:20:43.784Z</modification><creation>2026-04-15T03:09:54.923Z</creation></dates><accession>S-EPMC12196505</accession><cross_references><pubmed>40573219</pubmed><doi>10.3390/ph18060824</doi></cross_references></HashMap>